Wellgistics, a known face in the integration of technology and physical healthcare infrastructure for the major prescription drugs, have introduced EinsteinRx™. The EinsteinRx™ is a new premier prescription management solution to unify technology and physical infrastructure for the prescription drug company. This new solution enables a fully customizable, easy-going flow of information travelling as it is from the physician's desk to the pharmacy’s screen.
It also helps integrate drug manufacturing data, patient data, prescription fulfilment data, nutritional recommendations, and insurance information data to serve an optimal value-added solution for all crucial stakeholders.
EinsteinRx is a beneficial and suitable solution for self-insured employers, HMOs and GPOs that are seeking full full-fledged unified solution to maintain and balance their prescription drug programs. The company hopes to land with the new payer clients in this year’s fourth quarter. With this solution, the patients will be provided with the most befitting drug at an affordable price for pickup at the nearest location for a better home delivery experience.
A home delivery of well-trimmed nutritional recommendations to refine health while on medication. The system is refined to mitigate the potential drug-drug interactions (DDIs), while returning major data to the physician, like during the scenario when a prescription is followed, thus enabling space for excellent monitoring of patient adherence. EinsteinRx, as the premier AI prescription management hub solution, will accelerate the growth and development in both the healthtech and AI sectors, popularly adopting transformation in the healthcare sector.
The RPh, President and Interim-CEO of Wellgistics, Prashant Patel, said, “I’ve had a better time and experience of my career creating and executing technology to enhance the way pharmacies run business. We’ve completed the intricate task of coding the numerous joints of our ‘Pharmacy IT Railroad’ that will enable the refined data forth between the major stakeholders in a sincere way that is refined for pharmacy robust practices.”
Mr Patel added, “This new solution promises to close several loopholes in the pharmaceutical distribution process, and the patient group will enjoy access to the suitable drug at an affordable price. Alongside the physicians will also have a well-aware mind knowing their patients are dosed with their prescriptions and manufacturers understand their role with patients and pharmacists. Including the nutritional recommendations is provided to contribute to the drug’s efficacy and safety.”